Titlebook: Genome Editing in Biomedical Sciences; Geraldo A. Passos Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licens

轉(zhuǎn)變

書目名稱Genome Editing in Biomedical Sciences影響因子(影響力)




書目名稱Genome Editing in Biomedical Sciences影響因子(影響力)學(xué)科排名




書目名稱Genome Editing in Biomedical Sciences網(wǎng)絡(luò)公開度




書目名稱Genome Editing in Biomedical Sciences網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Genome Editing in Biomedical Sciences被引頻次




書目名稱Genome Editing in Biomedical Sciences被引頻次學(xué)科排名




書目名稱Genome Editing in Biomedical Sciences年度引用




書目名稱Genome Editing in Biomedical Sciences年度引用學(xué)科排名




書目名稱Genome Editing in Biomedical Sciences讀者反饋




書目名稱Genome Editing in Biomedical Sciences讀者反饋學(xué)科排名

Oafishness

https://doi.org/10.1007/978-3-531-90712-3We conclude that gene editing has been able to change quickly the scenario of these disorders, allowing the development of new therapies and improving the knowledge on disease pathogenesis. Should they confirm their hype, the first gene editing-based products for lysosomal disorders could be available in the next years.

1分開

Genome Editing Tools for Lysosomal Storage Disorders,We conclude that gene editing has been able to change quickly the scenario of these disorders, allowing the development of new therapies and improving the knowledge on disease pathogenesis. Should they confirm their hype, the first gene editing-based products for lysosomal disorders could be available in the next years.

結(jié)果

Ringworm

點(diǎn)燃

,Friendship in the Fathers’ Later Lives,icroRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thyroid cancer cell lines. In this chapter, we explore some of the current studies in which researchers have applied CRISPR/Cas9 in vitro to investigate thyroid cancer biology (Fig. .).

點(diǎn)燃

The CRISPR/Cas System in Human Cancer,llular and animal model generation, and new derivative tools applied to cancer research. CRISPR has opened new frontiers increasing the knowledge about cancer, pointing to new solutions to overcome several challenges to better understand the disease and design better treatments.

脆弱么

Using CRISPR/Cas9 to Edit a Thyroid Cancer Cell Line,icroRNAs and long noncoding RNAs. In this context, CRISPR/Cas9 emerges as a potential tool to modify gene sequence and modulate gene expression in thyroid cancer cell lines. In this chapter, we explore some of the current studies in which researchers have applied CRISPR/Cas9 in vitro to investigate thyroid cancer biology (Fig. .).

flimsy

Joanne M. McKeown,Catherine G. FineNA targeting in tumorigenesis and drug resistance. Additionally, we highlighted the perspectives and potential applications of CRISPR approaches to treat cancer, as an emerging and promising target therapy.

會犯錯誤